AI Agents for Multimodal Oncology Diagnosis: Toward Transparent and Traceable Clinical Decision Support
Liuyang Yang, Liyu Shan, Xiangmei Yao, Renbin Zhao, Zengzheng Li, Shuai Feng, Yajie Wang, Matthew Balcarras, Rashad Ismayilov, Javad Omidi · 2026
Read AI Agents for Multimodal Oncology Diagnosis: Toward Transparent and Traceable Clinical Decision Support by Liuyang Yang, Liyu Shan, Xiangmei Yao, Renbin Zhao, Zengzheng Li, Shuai Feng, Yajie Wang, Matthew Balcarras, Rashad Ismayilov, Javad Omidi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624588.txt.
Description
Liuyang Yang and co-authors set out a view on AI agents for cancer diagnosis in 2026. The work uses team framing since the head byline is shorter than the catalog list. Cancer care draws on scans, tissue slides, gene data, labs, and records. Most AI tools stay narrow. They sit apart from the back and forth of real diagnosis.
An agent, in their terms, keeps task state and picks governed tools. It watches results and revises its plan under safety rules. That sets agents apart from plain large models or fixed flows. The authors sort proof into agent level, part level, and proposed. They call for failure handling and doctor authority. Near term value lies in clear, traceable support.
Catalog record
| CREATOR | Liuyang Yang, Liyu Shan, Xiangmei Yao, Renbin Zhao, Zengzheng Li, Shuai Feng, Yajie Wang, Matthew Balcarras, Rashad Ismayilov, Javad Omidi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |